312 related articles for article (PubMed ID: 24459782)
1. 2013 State Compounding Legislation Tracker.
Miller DG
Int J Pharm Compd; 2013; 17(5):375-8. PubMed ID: 24459782
[No Abstract] [Full Text] [Related]
2. Compounding interest: a tragedy caused by contaminated steroids turned the spotlight on compounding pharmacies.
Hinkley KN
State Legis; 2013 Jun; 39(6):22-3. PubMed ID: 23805443
[No Abstract] [Full Text] [Related]
3. Compounding pharmacies: before and after an inspection.
Kulkarni D; Ricketts S
Int J Pharm Compd; 2013; 17(5):358-62. PubMed ID: 24459779
[TBL] [Abstract][Full Text] [Related]
4. The "Lists": What Do They Mean?
Voliva J
Int J Pharm Compd; 2016; 20(6):477-479. PubMed ID: 28339386
[No Abstract] [Full Text] [Related]
5. U.S. Food and Drug Administration List of Drugs NOT to be Used in Compounded Medications for Humans (The Negative List).
Int J Pharm Compd; 2016; 20(6):457-458. PubMed ID: 28339383
[No Abstract] [Full Text] [Related]
6. Drugs: just a click away. Online pharmacies can make dangerous drugs easy to get, but also can promote better health care. Should we regulate them?
Brand R
State Legis; 2007 Jun; 33(6):45, 47, 49. PubMed ID: 17546803
[No Abstract] [Full Text] [Related]
7. FDA, states discuss pharmacy compounding regulatory framework.
Traynor K
Am J Health Syst Pharm; 2013 Feb; 70(3):180, 182. PubMed ID: 23327976
[No Abstract] [Full Text] [Related]
8. Improving and enforcing compounding pharmacy practices to protect patients.
Pegues DA
Clin Infect Dis; 2006 Oct; 43(7):838-40. PubMed ID: 16941363
[No Abstract] [Full Text] [Related]
9. Regulating compounding pharmacies after NECC.
Outterson K
N Engl J Med; 2012 Nov; 367(21):1969-72. PubMed ID: 23134357
[No Abstract] [Full Text] [Related]
10. Introduction to Quality Control in a Compounding Pharmacy.
Allen LV
Int J Pharm Compd; 2016; 20(6):481-484. PubMed ID: 28339387
[TBL] [Abstract][Full Text] [Related]
11. Compounding practices in Iran.
Goodarzi N; Niknam S; Akbarzadeh T; Gholami K
Int J Pharm Compd; 2014; 18(2):112-6. PubMed ID: 24881113
[TBL] [Abstract][Full Text] [Related]
12. Pharmaceutical compounding or pharmaceutical manufacturing? A regulatory perspective.
Timko RJ; Crooker PE
Int J Pharm Compd; 2014; 18(2):101-11. PubMed ID: 24881112
[TBL] [Abstract][Full Text] [Related]
13. Regulating Compounding Pharmacies.
Noble A
NCSL Legisbrief; 2016 Nov; 24(42):1-2. PubMed ID: 27911513
[No Abstract] [Full Text] [Related]
14. The International Academy of Compounding Pharmacists: Government Affairs Lookback on 2017 Accomplishments and Look Ahead at 2018 Initiatives.
Blankenship C
Int J Pharm Compd; 2018; 22(1):26-28. PubMed ID: 29385383
[No Abstract] [Full Text] [Related]
15. GMPs vs GCPs: manufacturing and compounding definitions.
Allen LV
Int J Pharm Compd; 2013; 17(5):356. PubMed ID: 24459778
[No Abstract] [Full Text] [Related]
16. Meningitis outbreak shines light on compounding pharmacies.
Shaughnessy AF
BMJ; 2012 Nov; 345():e7432. PubMed ID: 23129491
[No Abstract] [Full Text] [Related]
17. Compounding USP <797>: inspection, regulation, and oversight of sterile compounding pharmacies.
Kastango ES
JPEN J Parenter Enteral Nutr; 2012 Mar; 36(2 Suppl):38S-39S. PubMed ID: 22275322
[TBL] [Abstract][Full Text] [Related]
18. International Academy of Compounding Pharmacists' recommendations for state-based legislative and regulatory initiatives.
Miller DG
Int J Pharm Compd; 2013; 17(1):48-9. PubMed ID: 23627246
[No Abstract] [Full Text] [Related]
19. Regulation of compounding by the food and drug administration: a tale of 2 circuits.
Williams KG
J Pharm Pract; 2010 Oct; 23(5):502-6. PubMed ID: 21507854
[TBL] [Abstract][Full Text] [Related]
20. U.S. Food and Drug Administration Inspections: Guide to a Successful Outcome for 503A Sterile Compounding Pharmacies.
Yoch D
Int J Pharm Compd; 2017; 21(2):95-102. PubMed ID: 28346203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
